Home › Funds › ABSHER WEALTH MANAGEMENT, LLC › ABT

ABSHER WEALTH MANAGEMENT, LLC position in ABT

ABBOTT LABORATORIES · Health Care

ABSHER WEALTH MANAGEMENT, LLC reported holding 457,861 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$45.3M, representing 5.05% of its reported portfolio and ranking #2 among its reported holdings. ABSHER WEALTH MANAGEMENT, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)457.86K sh
Reported value held$45.25M
Portfolio Weight5.05%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ABSHER WEALTH MANAGEMENT, LLC's ABT position evolved

ABSHER WEALTH MANAGEMENT, LLC first disclosed a stake in ABT in Q3 2023 at 182,867 shares (US$17.7M). The position peaked in Q3 2026 at 457,861 shares, worth US$45.3M. Across 13 filings, ABSHER WEALTH MANAGEMENT, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 457,861 shares valued at US$45.3M — an increase of 10,278 shares quarter over quarter.. Notable position changes include a 69% increase in Q1 2026 (shares fell 11% over the following quarter), a 34% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 182.87K $17.71M New
Q4 2023 185.08K $20.37M Add
Q1 2024 182.99K $20.80M Reduce
Q2 2024 183.84K $19.10M Hold
Q3 2024 175.73K $20.04M Reduce
Q4 2024 177.12K $20.03M Add
Q1 2025 157.95K $20.95M Reduce
Q2 2025 156.11K $21.23M Reduce
Q3 2025 158.15K $21.18M Add
Q4 2025 197.28K $24.72M Add
Q1 2026 333.13K $34.20M Add
Q2 2026 447.58K $40.61M Add
Q3 2026 457.86K $45.25M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has ABSHER WEALTH MANAGEMENT, LLC held ABT?

ABSHER WEALTH MANAGEMENT, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ABSHER WEALTH MANAGEMENT, LLC's current position in ABT?

As of Q3 2026, ABSHER WEALTH MANAGEMENT, LLC holds 457.86K shares of ABT (ABBOTT LABORATORIES), valued at $45.25M, representing 5.05% of its reported portfolio and ranking #2.

Has ABSHER WEALTH MANAGEMENT, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), ABSHER WEALTH MANAGEMENT, LLC increased its position in ABT. The position peaked in Q3 2026 at 457.86K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.